Scarica l'app Stockscreener
24.53
4.40%
-1.13
Pre-mercato:
25.26
0.73
+2.98%
Precedente Chiudi:
$25.66
Aprire:
$25.5
Volume 24 ore:
749.20K
Relative Volume:
0.88
Capitalizzazione di mercato:
$1.50B
Reddito:
-
Utile/perdita netta:
$-197.68M
Rapporto P/E:
-6.5239
EPS:
-3.76
Flusso di cassa netto:
$-158.88M
1 W Prestazione:
-7.92%
1M Prestazione:
-17.93%
6M Prestazione:
+177.49%
1 anno Prestazione:
+225.33%
Intervallo 1D:
$24.01
$26.05
Intervallo di 1 settimana:
$24.01
$29.49
Portata 52W:
$1.92
$31.18
Kodiak Sciences Inc Stock (KOD) Company Profile
Nome
Kodiak Sciences Inc
Settore
Industria
Telefono
650-281-0850
Indirizzo
1250 PAGE MILL RD, PALO ALTO, CA
Confronta KOD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
24.53 | 1.57B | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-11 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-09-25 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-09-22 | Iniziato | Jefferies | Buy |
| 2025-08-14 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-12-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-05 | Iniziato | H.C. Wainwright | Neutral |
| 2023-12-11 | Ripresa | Goldman | Sell |
| 2023-11-17 | Aggiornamento | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | Downgrade | UBS | Buy → Neutral |
| 2023-07-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-07-24 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2022-11-15 | Iniziato | CapitalOne | Overweight |
| 2022-08-02 | Downgrade | Citigroup | Neutral → Sell |
| 2022-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2021-03-12 | Iniziato | Evercore ISI | Outperform |
| 2021-03-01 | Downgrade | Barclays | Equal Weight → Underweight |
| 2021-02-17 | Downgrade | ROTH Capital | Buy → Neutral |
| 2021-01-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-12-11 | Iniziato | Citigroup | Neutral |
| 2020-11-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-11-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-31 | Iniziato | BMO Capital Markets | Outperform |
| 2020-03-03 | Iniziato | Goldman | Buy |
| 2020-02-18 | Downgrade | Barclays | Overweight → Equal Weight |
| 2020-02-06 | Iniziato | SunTrust | Buy |
| 2020-01-08 | Iniziato | ROTH Capital | Buy |
| 2020-01-03 | Iniziato | Jefferies | Buy |
| 2019-12-24 | Iniziato | JP Morgan | Overweight |
| 2019-10-15 | Reiterato | Chardan Capital Markets | Buy |
| 2019-02-20 | Iniziato | Chardan Capital Markets | Buy |
| 2018-10-29 | Iniziato | Barclays | Overweight |
| 2018-10-29 | Iniziato | BofA/Merrill | Buy |
| 2018-10-29 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Kodiak Sciences Inc Borsa (KOD) Ultime notizie
FY2025 EPS Estimates for Kodiak Sciences Lifted by Analyst - MarketBeat
Head to Head Review: Structure Therapeutics (NASDAQ:GPCR) and Kodiak Sciences (NASDAQ:KOD) - Defense World
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 7.6%Here's Why - MarketBeat
HC Wainwright Predicts Kodiak Sciences FY2030 Earnings - MarketBeat
Kodiak Sciences Reaches Analyst Target Price - Nasdaq
Kodiak Sciences (NASDAQ:KOD) Concentrates on Vision Preservation - Kalkine Media
Kodiak Sciences stock price target raised to $38 from $26 at H.C. Wainwright By Investing.com - Investing.com Nigeria
Kodiak Sciences stock price target raised to $38 from $26 at H.C. Wainwright - Investing.com Nigeria
KOD: Analyst Raises Price Target to $38 with Buy Rating | KOD St - GuruFocus
H.C. Wainwright Maintains Kodiak Sciences(KOD.US) With Buy Rating, Raises Target Price to $38 - 富途资讯
Kodiak Sciences (KOD) Valuation Check As Phase 3 Readouts And Capital Raise Focus Investor Attention - Sahm
Kodiak Sciences Is Riding A 325% Run Into Big Retina Readouts - Finimize
Aug Weekly: Is Kodiak Sciences Inc exposed to currency risksStop Loss & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Why Kodiak Sciences Inc. stock is in analyst buy zoneMarket Performance Report & Technical Analysis for Trade Confirmation - bollywoodhelpline.com
Chart Watch: Can Kodiak Sciences Inc lead its sector in growthJuly 2025 Technicals & Entry Point Confirmation Alerts - baoquankhu1.vn
Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Update - MarketBeat
First Week of December 18th Options Trading For Kodiak Sciences (KOD) - Nasdaq
Kodiak Sciences (KOD) Price Target Increased by 24.19% to 28.05 - Nasdaq
Is Kodiak Sciences Inc. (K27) stock included in top ETFsStock Screening Results & Exceptional Growth Portfolio - bollywoodhelpline.com
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 7.7%Here's What Happened - MarketBeat
Hedge Fund Bets: Will Kodiak Sciences Inc benefit from seasonalityRate Hike & Safe Entry Momentum Tips - baoquankhu1.vn
Is It Too Late To Consider Kodiak Sciences (KOD) After Its 233% One-Year Surge? - Yahoo Finance
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Kodiak Sciences (KOD) price target increased by 19.36% to 21.71 - MSN
How analysts rate Kodiak Sciences Inc. stock todayQuarterly Portfolio Report & Risk Controlled Swing Trade Alerts - ulpravda.ru
Kodiak Sciences (NASDAQ:KOD) Rating Increased to Strong-Buy at UBS Group - MarketBeat
Is Kodiak Sciences Inc. (K27) stock inflation resilient2025 Stock Rankings & Momentum Based Trading Signals - Улправда
Will Kodiak Sciences Inc. stock outperform value stocksTake Profit & Accurate Entry/Exit Alerts - ulpravda.ru
Is Kodiak Sciences (KOD) Pricing Reflect Recent Biotech Pipeline And Funding Developments Accurately - Sahm
Is Kodiak Sciences Inc. stock safe for conservative investorsWatch List & AI Powered Trade Plan Recommendations - Улправда
Can Kodiak Sciences Inc. stock weather global recessionJuly 2025 Institutional & Fast Moving Stock Trade Plans - Улправда
Is Kodiak Sciences Inc. (K27) stock ideal for retirement investors2025 EndofYear Setup & Risk Managed Investment Entry Signals - ulpravda.ru
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference - MEXC
Retina biotech Kodiak Sciences to present at major J.P. Morgan event - Stock Titan
UBS Initiates Coverage of Kodiak Sciences (KOD) with Buy Recommendation - Nasdaq
KOD: UBS Initiates Coverage with 'Buy' Rating and $50 Price Targ - GuruFocus
Kodiak Sciences (NASDAQ:KOD) Shares Gap UpHere's Why - MarketBeat
UBS initiates Kodiak Sciences stock with Buy rating, $50 price target By Investing.com - Investing.com South Africa
UBS initiates Kodiak Sciences stock with Buy rating, $50 price target - Investing.com Australia
PRN_FinancialWrapper | PR NewswireKodiak Sciences IncCommon Stock (Nasdaq:KOD) Detailed Stock Data - FinancialContent
Kodiak Sciences launches public offering of 6 mln shares - MSN
Volume Recap: Why GeneDx Holdings Corp Equity Warrant stock is rated strong buy - moha.gov.vn
Will Kodiak Sciences Inc stock outperform value stocksProfit Target & Long Hold Capital Preservation Plans - moha.gov.vn
Is Kodiak Sciences Inc a good long term investmentInsider Selling Patterns & Low Entry Investment Ideas - Early Times
Kodiak Sciences Inc Stock Analysis and ForecastPrice Action Trading & Exceptional Capital Investment - earlytimes.in
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.8%Here's Why - MarketBeat
The Biggest IPO of the Year Prompts Huge Insider Buy - AOL.com
Investors Buy Big as Medline’s IPO Raises Over $6 Billion - cointurk finance
Kodiak Sciences Inc Azioni (KOD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):